Programme NCHIV20virtual (subject to change)

Tuesday 24 November 09:00 - 11:40: Session 1
Session 1HIV: think globally, act locally
Chairs: Frank Cobelens (Amsterdam UMC-AMC; AIDHG) & Kim Sigaloff (Amsterdam UMC-VUmc)
09:00 - 09:10Welcome and introductionsPeter Reiss (SHM; Amsterdam UMC-AMC; AIGHD)
Kim Sigaloff (Amsterdam UMC-VUmc)
09:10 - 09:30Plenary: Tuberculosis in the face of two global viral pandemicsSabine Hermans (AIGHD; Amsterdam UMC-AMC)
09:30 - 09:40Moderated Q&A
09:40 - 10:05Promoting indicator condition-guided testing for HIV in the hospital setting (PROTEST 2.0): Baseline results of a multicentre intervention study Saskia Bogers (Amsterdam UMC-AMC)
Improving the HIV testing cascade: adequate identification of patients with HIV indicator conditions in hospitals by electronic registration systems On behalf of the project group Carlijn Jordans (Erasmus MC)
Large regional variation across the Netherlands in the number of people living with undiagnosed HIVArd van Sighem (SHM)
10:05 - 10:15Moderated Q&A
10:15 - 10.25Short break
10:25 - 10:45Highlights 2020 NL HIV Monitoring ReportAnders Boyd (GGD Amsterdam; SHM)
Ard van Sighem SHM)
Colette Smit (SHM)
Ferdinand Wit (SHM; Amsterdam UMC-AMC)
10:45 - 11:05Panel discussion 2020 NL Monitoring Report. We have the data... what's next?Anders Boyd (GGD Amsterdam; SHM)
Ard van Sighem SHM)
Colette Smit (SHM)
Ferdinand Wit (SHM; Amsterdam UMC-AMC)
Kim Sigaloff (Amsterdam UMC-VUmc)
Mark Vermeulen (Aidsfonds)
11:05 - 11:10Close
11:10 - 11:45Parallel oral poster presentations of 5 minutes each followed by non-moderated Q&A
Tuesday 24 November 15:00 - 17:15: Session 2
Session 2Antiretroviral therapy: novel options and how to implement them
Chairs: TBA
15:00 - 15:05Welcome and introductions
15:05 - 15:25Plenary: Novel Antiretroviral Treatments and StrategiesDaniel Kuritzkes (Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA)
15:25 - 15:35Moderated Q&A
15:35 - 16:00Lower incidence of viral blips: another finding to favor the use of INSTI-based cAR Suzan Dijkstra (UMC Utrecht)
A population pharmacokinetic analysis assessing the exposure of raltegravir once-daily 1200mg in pregnant women living with HIVVera Bukkems (Radboudumc)
Prevalence, correlates and health impact of healthcare provider counseling about undetectable equals untransmittable (u=u): findings from the Netherlands and other European CountriesBart Lammertink (ViiV Healthcare)
16:00 - 16:10Moderated Q&A
16:10 - 16:20Short break
16:20 - 17:00Panel: Implementing long-acting antivirals for treatment and prevention in practice Renee Finkenflügel (Hiv vereniging)
Emilie Gieling (UMC Utrecht)
Noëmi Nijsten GGD Gelderland-Zuid
Karin Grintjes (Radboudumc)
Sjoerd Repping (Amsterdam UMC-AMC; Zorginstituut Nederland
Moderator: Marc van der Valk (Amsterdam UMC-AMC)
17:00- 17:05Close
Thursday 26 November 09:00 - 11:40: Session 3
Session 3Curing HIV and hepatitis: now and in the future
Chairs: Marit van Gils (Amsterdam UMC-AMC) & Casper Rokx (Erasmus MC)
09:00 - 09:10Welcome and introductions
09:10 - 09:30Plenary: Advances towards an HBV cure: lessons for HIV cure strategiesSharon Lewin (University of Melbourne, Australia)
09:30 - 09:40Moderated Q&A
09:40 - 10:05HCV micro-elimination in HIV-positive individuals in the Netherlands: four years after universal access to direct-acting antivirals Colette Smit (SHM)
HIV-specific CD8+ T-cells from elite controllers display a gene expression profile associated with increased functionalityLisa van Pul (Amsterdam UMC-AMC)
Antibody engineering to improve Fc effector function and therapeutic application of HIV-1 bNAbs Steven de Taeye (Amsterdam UMC-AMC)
10:05 - 10:15Moderated Q&A
10:15 - 10:25Short break
10:25 - 10:50Locking & Unlocking Sexual Health for MSMModerators: Febe Deug (Aidsfonds) & Vanessa Harris (Amsterdam UMC-AMC; AIGHD)
Impact of COVID-19 measures on patterns of sexual activity and risk of HIV or STI acquisition among MSM living in the Netherlands Philippe Adam (Institute for Prevention and Social Research in Health )
The effect of COVID-19 restrictions on daily sexual behavior and pre-exposure prophylaxis use among men who have sex with men Vita Jongen (GGD Amsterdam)
Never tested for HIV: directions for a targeted testing intervention among men who have sex with men Hanne Zimmermann (GGD Amsterdam)
10:50 - 11:00Moderated Q&A
11:00 - 11:05Close
11:05 - 11:40Parallel oral poster presentations of 5 minutes each followed by non-moderated Q&A
Thursday 26 November 15:00 - 17:30: Session 4
Session 4HIV prevention and cure: how to best serve the client and outsmart the virus
Chairs: Godelieve de Bree & Marit van Gils (Amsterdam UMC-AMC)
15:00 - 15:05Welcome and introductions
15:05 - 15:25Plenary: What Participants Know: The Critical Role of Socio-Behavioral Sciences in HIV Cure ResearchKarine Dubé (University of North Carolina, Gillings School of Public Health, USA)
15:25 - 15:35Moderated Q&A
15:35 - 16:00HIV-1 Subverts the complement system to escape degradation and promote viral dissemination Marta Bermejo Jambrina (Amsterdam UMC-AMC)
Changes in condomless anal sex and sexually transmitted infections after PrEP initiation among men who have sex with men: a comparison of PrEP users to non-PrEP users Liza Coyer (GGD Amsterdam)
Enhancing and directing neutralizing antibody responses by ultrastabilization of HIV-1 envelope trimers and masking immunodominant epitopes Iván del Moral Sánchez (Amsterdam UMC-AMC)
16:00 - 16:10Moderated Q&A
16:10 - 16:15Award ceremony: 2020 Joep de Lange & Jacqueline van Tongeren Award
16:15 - 16:25Short break
16:25 - 17:25The tale of two pandemics, what can one teach us in facing the other? (This session will be held in Dutch) A conversation between Yvonne van Duijnhoven (Head of Infectious disease control Public Health Services) and Roel Coutinho (former head of Public Health Service Amsterdam, and former Director or the National Institute for Public Health and the Environment), led by Coen Verbraak (journalist and program director)
17:25 - 17:30CloseMarit van Gils (Amsterdam UMC-AMC)
Peter Reiss (SHM; Amsterdam UMC-AMC; AIGHD)
Kim Sigaloff (Amsterdam UMC-VUmc)
Register Accreditation